# AbbVie Bioresearch Center - Inspection Records

Source: https://www.globalkeysolutions.net/companies/abbvie-bioresearch-center/6957449c-4de8-444b-b53c-5838b33a76a1

> Inspection records and compliance data for AbbVie Bioresearch Center in Worcester, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: AbbVie Bioresearch Center
- FEI Number: 3003684386
- City: Worcester
- State: Massachusetts
- Country Name: United States
- Address Line 1: 100 Research Dr
- Zip Code: 01605

## Related Documents

- [483 - AbbVie Bioresearch Center - Unknown Date](https://www.globalkeysolutions.net/records/483/abbvie-bioresearch-center/80e5e8eb-3991-4bd1-974d-279b0bbf2aba) — source: FDA, date: Invalid Date
- [483 - AbbVie Bioresearch Center - 2025-12-16](https://www.globalkeysolutions.net/records/483/abbvie-bioresearch-center/23610032-b531-463c-919f-799b7894969b) — source: FDA, date: December 16, 2025
- [FDA Inspection 1295502 - AbbVie Bioresearch Center - 2025-12-16](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-bioresearch-center/9cda06b1-831d-4b36-857f-63c6870cb2f2) — source: FDA, date: December 16, 2025
- [FDA Inspection 1272372 - AbbVie Bioresearch Center - 2025-09-05](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-bioresearch-center/a91f3c86-0711-4246-bb8c-49db637cf181) — source: FDA, date: September 5, 2025
- [FDA Inspection 1272372 - AbbVie Bioresearch Center - 2025-09-05](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-bioresearch-center/62e48af3-158e-4ea2-825c-b7814b355fae) — classification: No Action Indicated (NAI), source: FDA, date: September 5, 2025
- [EIR - AbbVie Bioresearch Center - 2019-11-18](https://www.globalkeysolutions.net/records/eir/abbvie-bioresearch-center/65ba65b3-8ebe-41c9-af3a-880b8c84a775) — source: FDA, date: November 18, 2019
- [FDA Inspection 1113080 - AbbVie Bioresearch Center - 2019-11-18](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-bioresearch-center/6bcbcb7c-5867-46ff-8112-ae1049d1a8a3) — classification: No Action Indicated (NAI), source: FDA, date: November 18, 2019
- [EIR - AbbVie Bioresearch Center - 2018-05-24](https://www.globalkeysolutions.net/records/eir/abbvie-bioresearch-center/dd106705-3ed4-4568-a1bc-df4b07029ec0) — source: FDA, date: May 24, 2018
- [FDA Inspection 1056813 - AbbVie Bioresearch Center - 2018-05-24](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-bioresearch-center/af6c0040-d422-4837-951e-f4145a5230be) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 24, 2018
- [FDA Inspection 1010336 - AbbVie Bioresearch Center - 2017-04-11](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-bioresearch-center/78cede5c-81b6-4b90-8967-5f44158e47c2) — classification: No Action Indicated (NAI), source: FDA, date: April 11, 2017
- [FDA Inspection 972163 - AbbVie Bioresearch Center - 2016-04-20](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-bioresearch-center/04a6cb88-8a10-4841-8c3b-126407d289d7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 20, 2016
- [FDA Inspection 935478 - AbbVie Bioresearch Center - 2015-06-11](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-bioresearch-center/caf8bea3-ed64-4d78-a592-9b15621eed38) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 11, 2015
- [FDA Inspection 877144 - AbbVie Bioresearch Center - 2014-04-03](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-bioresearch-center/4e784055-7eaa-4b4b-8faf-a342ed2b1a44) — classification: No Action Indicated (NAI), source: FDA, date: April 3, 2014
- [FDA Inspection 810533 - AbbVie Bioresearch Center - 2012-12-07](https://www.globalkeysolutions.net/records/fda_inspections/abbvie-bioresearch-center/6bdd8ba7-15dc-48f7-825f-fd8bc64a6d16) — classification: No Action Indicated (NAI), source: FDA, date: December 7, 2012

## Related Companies

- [Taixing SynTheAll Pharmaceutical Co., Ltd](https://www.globalkeysolutions.net/companies/taixing-syntheall-pharmaceutical-co-ltd/7acaa1ac-b9fc-4fed-8ac5-a6b413bdf3e1)
- [Eriochem SA](https://www.globalkeysolutions.net/companies/eriochem-sa/e2f01909-c1a5-49e0-a736-041a0c65beba)
- [Baxalta Manufacturing Sarl](https://www.globalkeysolutions.net/companies/baxalta-manufacturing-sarl/71d79fb0-4c45-4139-b2d0-a6e38551344e)
- [Sucampo Pharma, LLC](https://www.globalkeysolutions.net/companies/sucampo-pharma-llc/5a5bffc7-663f-47ab-8ccf-2078e2f49f60)
- [Immunex Rhode Island Corporation](https://www.globalkeysolutions.net/companies/immunex-rhode-island-corporation/c70ebfcc-0c4d-4294-845a-24f1af8f30e9)
- [Sanofi Winthrop Industrie](https://www.globalkeysolutions.net/companies/sanofi-winthrop-industrie/f7668868-7954-441c-b8bf-ab135e8645c2)
- [Viatris Pharmaceuticals LLC](https://www.globalkeysolutions.net/companies/viatris-pharmaceuticals-llc/86ee0564-73c3-4575-acbc-56fb8e87627c)
- [Asymchem Life Science (Tianjin) Co., Ltd.](https://www.globalkeysolutions.net/companies/asymchem-life-science-tianjin-co-ltd/ccb993d1-42a4-40fe-9c05-bf590f287eeb)
- [Merz Pharma GmbH & Co., KGaA](https://www.globalkeysolutions.net/companies/merz-pharma-gmbh-co-kgaa/758203de-10f2-4cff-a0ca-d3b1152277c0)
- [Vistin Pharma AS avd Kragero Fikkjebakke](https://www.globalkeysolutions.net/companies/vistin-pharma-as-avd-kragero-fikkjebakke/6acc0a66-9192-481c-a1bf-4d4d0cbf68e7)

## Related Officers

- [Qing Zhou PhD., Senior Staff Fellow](https://www.globalkeysolutions.net/people/qing-zhou-phd-senior-staff-fellow/18de93e1-6510-452e-b041-c4fcbca23f8b)
- [Jun Park PhD. Biologist](https://www.globalkeysolutions.net/people/jun-park-phd-biologist/6c1b59d2-d8ef-4e47-90e5-1298d7a42c94)
- [recipient](https://www.globalkeysolutions.net/people/robert-t-ohagan/0e9dc7f7-ffc5-49d8-8c76-026f6ddd12f7)
- [company_representative](https://www.globalkeysolutions.net/people/miriam-ferrell/27be6d99-106a-485f-89bb-4dfdbbaaea5f)
- [company_representative](https://www.globalkeysolutions.net/people/ivone-colaco/20254bd7-c557-499f-bd1e-3e22c025c8dd)